We are live on ! Find out more
BIAFW icon

bioAffinity Technologies
BIAFW

4 hedge funds and large institutions have $101K invested in bioAffinity Technologies in 2024 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4 → 4 (0)

0.46% less ownership

Funds ownership: 3.19% → 2.73% (-0.46%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

55% less capital invested

Capital invested by funds: $226K → $101K (-$125K)

Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CS
Clear Street
New York
+$7.36K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$930
2
WAM
Warberg Asset Management
Illinois
-$571
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$61.3K – – –
CS
2
Clear Street
New York
$19.8K +$7.36K +15,504 +31%
Citadel Advisors
3
Citadel Advisors
Florida
$14K -$930 -1,959 -8%
WAM
4
Warberg Asset Management
Illinois
$5.94K -$571 -1,203 -8%

BIAFW Hedge Fund Activity: Q2 2024 in Review

4 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q2 2024, worth a combined $101K — down 55% from $226K a quarter earlier.

Fund positioning in BIAFW was balanced in Q2 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 2 trimmed.

The largest buyer was Clear Street, adding an estimated $7.36K. The largest seller was Citadel Advisors, cutting an estimated $930.

  • 4 institutional investors held bioAffinity Technologies (BIAFW) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $101K of bioAffinity Technologies stock for Q2 2024, down 55% quarter-over-quarter.
  • 0 funds opened new bioAffinity Technologies positions in Q2 2024 and 0 closed out.
  • The largest bioAffinity Technologies buyer in Q2 2024 was Clear Street, an estimated $7.36K added.
  • The largest bioAffinity Technologies seller in Q2 2024 was Citadel Advisors, an estimated $930 sold.

Based on aggregated 13F filings for Q2 2024.